Consistent with the reports which provided evidence that the mitochondrial depolarization in lung cancer cells was due to the imbalance of Bax/Bcl-2 [50], we found that treatment with PRIS increased the cellular level of proapoptotic Bax and reduced the levels of antiapoptotic Bcl-2. Here, BCL2 is linked to lung cancer.